Experiment 393661
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Ginkgo biloba (GINKGOACEAE) |
| Citation | ITIL,TM: ERALP,E: AHMED,I: KUNITZ,A: ITIL,KZ:. (1998). THE PHARMACOLOGICAL EFFECTS OF GINKGO BILOBA, A PLANT EXTRACT, ON THE BRAIN OF DEMENTIA PATIENTS IN COMPARISON WITH TACRINE.. 34(3) |
| Amount utilized | |
| Compound isolated | |
| Disease | TO DETERMINE WHETHER EGB OR TACRINE HAD NOTICEABLE PHARMACOLOGICAL EFFECTS ON ELDERLY SUBJECTS DIAGNOSED WITH POSIBLE OR PROBABLE ALZHEIMER'S THE PRESENT OPEN, UNCONTROLLED TRIAL WAS CONDUCTED. DATA FROM 18 SUBJECTS (11 MALES, 7 FEMALES) AT AN AVERAGE AGE OF 67.4 YEARS WITH LIGHT TO MODERATE DEMENTIA (MINI MENTAL MEAN SCORE = 23.7, RANGES: 15-29 [GERIARIC DEPRESSION SCALE MEAN SCORES = 3.7; RANGE: 3.2.5.4]) WERE ANALYZED FOR THIS PRESENTATION. EACH SUBJECT WAS RANDOMLY ADIMIISTERED A SINGLE ORAL "TEST-DOSE" OF EITHER 40 MG OF TACRINE OR 240 MG OF EGB2. THE RESULTS ALSO SHOWED THAT 240 MG OF EGB HAS TYPICAL COGNITIVE ACTIVATOR CEEG PROFILES 9RESPONDERS) IN MORE SUBJECTS (8 OF 18) THAN 40 MG TACRINE (3 OF 18 SUBJECTS). |
| Dose amount | 240.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | ETOH(100%)EXT |
| Gender | GIVEN TO BOTH SEXES |